Master this deck with 20 terms through effective study methods.
Generated from uploaded pdf
Older antihistamines, such as astemizole and terfenadine, can pose significant risks for patients with pre-existing heart conditions due to their potential to cause arrhythmias and other cardiovascular issues.
Newer nonsedating antihistamines are designed to alleviate histamine-related symptoms without causing excessive sedation or neuropsychiatric effects, making them preferable for many patients.
Mucolytic drugs aim to decrease the viscosity of respiratory secretions, facilitating easier clearance of mucus from the airways.
Expectorants help to increase the production and ejection of mucus, preventing the accumulation of thick secretions that can obstruct respiratory passages.
Epinephrine can be administered via inhalation, intramuscular, and subcutaneous routes, with each method having specific indications and onset times.
Nebulizers may be a better option for patients who struggle with the technique required for metered-dose inhaler (MDI) delivery, ensuring effective medication administration.
Beta-2 agonists can cause side effects such as nervousness, confusion, and tremors, which may indicate bronchodilator toxicity and require medical attention.
Patients on systemic glucocorticoids may experience catabolic effects, leading to skin breakdown and increased risk of bone and musculotendinous injuries due to prolonged use.
Aerobic conditioning can enhance the overall health and well-being of asthma patients, although care must be taken as certain exercises may trigger asthma symptoms.
Chronic bronchitis is characterized by long-standing inflammation of the bronchial tree, leading to persistent cough and mucus production.
Emphysema is a pathological condition marked by the destruction of alveolar walls and enlargement of air spaces, leading to reduced gas exchange efficiency.
The primary goals include relieving bronchospasm, improving airflow, and enhancing the patient's quality of life through appropriate medication and lifestyle modifications.
Inhaled corticosteroids reduce inflammation in the airways, leading to decreased frequency and severity of asthma attacks.
Beta-2 adrenergic agonists work by stimulating beta-2 receptors in the bronchial smooth muscle, leading to bronchodilation and improved airflow.
Patients should be educated about the initiating factors of asthma attacks during their initial assessment and regularly throughout their treatment to help them avoid triggers.
Untreated bronchospasm in COPD can lead to severe respiratory distress, decreased oxygenation, and increased risk of respiratory failure.
Early recognition of bronchodilator toxicity is crucial as it can prevent serious complications and ensure timely intervention, especially in patients using xanthine derivatives.
DPIs offer portability and convenience similar to MDIs, allowing for easy administration of beta-2 drugs without the need for propellants.
Patients with asthma can safely engage in aerobic exercise by choosing low-risk activities, such as swimming, and ensuring proper management of their condition before exercise.
Individualized drug selection is important to find the antihistamine that provides effective symptom relief with the fewest side effects for each patient.